Please don't project your codependency
* Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005 Aug;118(8):881-4.
* Avorn J, Chen M, Hartley R. Scientific versus commercial sources of influence on the prescribing behavior of physicians. Am J Med. 1982;73:4-8.
* Caudill, TS, Johnson, MS, Rich EC, McKinney, WP. Physicians, pharmaceutical sales representatives, and the cost of prescribing. Arch of Fam Med. 1996;5:201-206.
* Chew, LD, et al. A Physician Survey of the Effect of Drug Sample Availability on Physicians' Behavior. J Gen Int Med. 2000;15: 478-483.
* Chren MM, Landefeld CS. Physicians' behavior and their interaction with drug companies. JAMA. 1994;271:684-689.
* Orlowski JP and Wateska L. The effects of pharmaceutical firm enticements on physician prescribing patterns. Chest. 1992; 102:270-273.
* Peay MY, Peay ER. The role of commercial sources in the adoption of a new drug. Soc Sci Med 1988;26:1183-9.
* Wazana A. Physicians and the Pharmaceutical Industry: Is a gift ever just a gift? JAMA. 2000;283:373-80.
* Cooper RJ, et al. The quantity and quality of scientific graphs in pharmaceutical advertisements. J Gen Intern Med. 2003 Apr;18(4):294-7.
* Shaughnessy AF, Slawson DC, Bennett JH. Separating the wheat from the chaff: identifying fallacies in pharmaceutical promotion. J of Gen Int Med. 1994; 10:563-8.
* Stryer, D and Bero, LA. Characteristics of materials distributed by drug companies. An evaluation of appropriateness. J Gen Int Med. 1996;11:575-583.
* Villanueva P, et al. Accuracy of pharmaceutical advertisements in medical journals. Lancet 2003; 361: 27-32.
* Wilkes MS, Doblin BH, Shapiro MF. Pharmaceutical advertisements in leading medical journals: experts assessments. Ann Intern Med 1992;116:912-9.
* Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995;273:1296-1298.Comments in JAMA. 1995;274:1267-1268.
* Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005 Aug;118(8):881-4
* Backer EL, et al. The value of pharmaceutical representative visits and medication samples in community-based family practices. J Fam Pract. 2000:49:811-6
* Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med. 2002 Nov-Dec;34(10):729-31
* Chew, LD, et al. A Physician Survey of the Effect of Drug Sample Availability on Physicians' Behavior. J Gen Int Med. 2000;15: 478-483
* Tong KL, Lien CY. Do pharmaceutical representatives misuse their drug samples? Can Fam Physician. 1995;41:1363-1366
* Ubel PA, Jepson C, Asch DA. Misperceptions about beta-blockers and diuretics: a national survey of primary care physicians. J Gen Intern Med. 2003;18(12):977-83
* Westfall JM, McCabe H, Nicholas RA. Personal use of drug samples by physicians and office staff. JAMA. 1997;278:141-143. Comments in JAMA. 1998;279:1698-99
How you like them apples chief?